UniXell Doses First Patient with UX-DA001 for Parkinson’s disease
May 23, 2025
Shanghai UniXell Biotechnology, a biotech company dedicated to innovative cell therapies, announced the successful first administration of its proprietary Parkinson’s disease cell drug UX-DA001 in China in March